Novan, Inc. Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Novan, Inc.
Pharmaceuticals
2023
Placement Agent Agreement, dated June 9, 2022, by and between the Company and Oppenheimer & Co. Inc
Novan, Inc.
Pharmaceuticals
2022
UNC Sublicense Agreement, dated December 29, 2015, by and between Novan, Inc. and KNOW Bio, LLC
Novan, Inc.
Pharmaceuticals
NC
2022
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Novan, Inc.
Pharmaceuticals
2022
Novan, Inc. Tangible Stockholder Return Plan, as amended and restated
Novan, Inc.
Pharmaceuticals
DE
2021
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Novan, Inc.
Pharmaceuticals
2021
Letter Amendment, dated
Novan, Inc.
Pharmaceuticals
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Novan, Inc.
Pharmaceuticals
2020
Second Amendment, dated November 2, 2018, to the UNC Sublicense Agreement, dated December 29, 2015, by and between Novan, Inc. and KNOW Bio, LLC
Novan, Inc.
Pharmaceuticals
2019
Tangible Stockholder Return Plan, dated August 2, 2018 (as amended and restated November 2, 2018)
Novan, Inc.
Pharmaceuticals
DE
2018
First Amendment, dated October 13, 2017, to the UNC Sublicense Agreement, dated December 29, 2015, by and between Novan, Inc. and KNOW Bio, LLC
Novan, Inc.
Pharmaceuticals
2018
Letter Agreement, dated October 31, 2017, by and between Novan, Inc. and William L. Hodges
Novan, Inc.
Pharmaceuticals
2017
Execution Copy
Novan, Inc.
Pharmaceuticals
2017
Execution Copy
Novan, Inc.
Pharmaceuticals
NC
2017
UNC SUBLICENSE AGREEMENT
Novan, Inc.
Pharmaceuticals
NC
2016
NOVAN, INC. 2016INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE
Novan, Inc.
Pharmaceuticals
DE
2016
NOVAN, INC. 2008 STOCKPLAN
Novan, Inc.
Pharmaceuticals
NC
2016